Business Description
WAVE Life Sciences Ltd
ISIN : SG9999014716
Compare
Compare
Traded in other countries / regions
WVE.USA1U5.Germany IPO Date
2015-11-11Description
WAVE Life Sciences Ltd is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.92 | |||||
| Equity-to-Asset | -0.23 | |||||
| Debt-to-Equity | -0.68 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -6.46 | |||||
| Beneish M-Score | -5.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -54 | |||||
| 3-Year EBITDA Growth Rate | 31 | |||||
| 3-Year EPS without NRI Growth Rate | 29 | |||||
| 3-Year FCF Growth Rate | 33.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.55 | |||||
| 9-Day RSI | 67.74 | |||||
| 14-Day RSI | 66.04 | |||||
| 6-1 Month Momentum % | -1.94 | |||||
| 12-1 Month Momentum % | 28.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.32 | |||||
| Quick Ratio | 1.32 | |||||
| Cash Ratio | 1.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -36.3 | |||||
| Shareholder Yield % | -3.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -372.6 | |||||
| Net Margin % | -358.93 | |||||
| ROA % | -63.18 | |||||
| ROIC % | -109.01 | |||||
| ROC (Joel Greenblatt) % | -308.56 | |||||
| ROCE % | -120.37 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.3 | |||||
| EV-to-EBIT | -3.23 | |||||
| EV-to-EBITDA | -3.48 | |||||
| EV-to-Revenue | 12.04 | |||||
| EV-to-Forward-Revenue | 44.02 | |||||
| EV-to-FCF | -35.73 | |||||
| Earnings Yield (Greenblatt) % | -30.96 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:WVE
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
WAVE Life Sciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 36.559 | ||
| EPS (TTM) ($) | -1.36 | ||
| Beta | -1.77 | ||
| Volatility % | 90.89 | ||
| 14-Day RSI | 66.04 | ||
| 14-Day ATR ($) | 0.440013 | ||
| 20-Day SMA ($) | 5.2165 | ||
| 12-1 Month Momentum % | 28.25 | ||
| 52-Week Range ($) | 3.04 - 7.12 | ||
| Shares Outstanding (Mil) | 98.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
WAVE Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
WAVE Life Sciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
WAVE Life Sciences Ltd Frequently Asked Questions
What is WAVE Life Sciences Ltd(WVE)'s stock price today?
The current price of WVE is $5.76. The 52 week high of WVE is $7.12 and 52 week low is $3.04.
When is next earnings date of WAVE Life Sciences Ltd(WVE)?
The next earnings date of WAVE Life Sciences Ltd(WVE) is 2023-11-10 Est..
Does WAVE Life Sciences Ltd(WVE) pay dividends? If so, how much?
WAVE Life Sciences Ltd(WVE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers